Notable Analyst Rating Changes 8/27: MKC, WBD, OKE Upgraded; AMLN, BKUNA, JCG, AXL Downgraded
More News related to AMLN
- Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
- Unusual 11 Mid-Day Movers 6/26: NCS, PALM, SCON, AMLN Higher; DWRI, GRB, BLUD, RBN Lower
- Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference
- Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
- Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
More News related to AXL
- Lear (LEA) Plummets as Company Edges Closer to Bankruptcy
- 'Cash for Clunkers' Passage Poised To Help Auto Companies and Suppliers (F, GMGMQ, LEA, ARM)
- Auto Suppliers Lower As No Additional Govenment Aid Seen (LEA, ARM, AXL)
- Unusual 11 Mid-Day Movers 6/17: SVNT, MIPI, MEA, ALVR Higher; STSI, AHT, ARM, AXL Lower
- Wachovia Reiterates a 'Market Perform' Rating on American Axle & Manufacturing (AXL); Raises 2010 Estimates
More News related to BKUNA
- Notice to All BankUnited Financial Corporation Shareholders From the Securities Law Firm of Tramont Guerra & Nunez, PA
- BankUnited Financial Corporation Commences Chapter 11 Process
- Top 10 News Items 5/18-5/22: S&P Places UK Ratings on Negative Outlook, Creating Fears That US Could Be Next; BankUnited Closed by Office of Thrift Supervision; 2 IPO's Hit the Market
- NASDAQ Changes Trading Halt Status of BankUnited Financial Corp.
- BankUnited (BKUNA) Closed By Office of Thrift Supervision, FDIC Appointed Receiver; John Kanas Group Buys Banking Operations
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Banc of America upgrades McCormick & Co. Inc. (NYSE: MKC) from Sell to Neutral.
UBS upgrades Wimm-Bill-Dann Foods (NYSE: WBD) from Neutral to Buy.
Lehman Bros. upgrades ONEOK (NYSE: OKE) from Equalweight to Overweight.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Robert W. Baird downgrades Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) from Buy to Neutral, saying the latest Byetta update reduces their conviction. The firm cut its price target from $37 to $27.
Natixis Bleichroeder downgrades Amylin Pharmaceuticals from Hold to Sell. Price target $22.
Soleil Securities downgrades Amylin Pharmaceuticals from Hold to Sell and lowers their price target from $25 to $20, following news of four additional deaths of patients on Byetta.
Stifel Nicolaus downgrades BankUnited Financial (Nasdaq: BKUNA) from Hold to Sell.
Brean Murray downgrades J. Crew Group, Inc. (NYSE: JCG) from Buy to Hold.
Robert W. Baird downgrades American Axle & Manufacturing (NYSE: AXL) from Outperform to Neutral with a $7 price target.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Lehman Bros. re-initiates coverage on Hewlett-Packard (NYSE: HPQ) with an Overweight rating.
Merriman Curhan initiates coverage on eHealth (Nasdaq: EHTH) with a Buy.
Needham & Co. initiates coverage on IXYS Corp (NASDAQ: IXYS) with a Hold rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.54
+23.94Related Entities
- Stifel Nicolaus
- Brean Murray Carret & Co.
- UBS
- Lehman Brothers
- Robert W Baird
- Needham & Co
- Soleil Securities
- Banc of America
- Merriman Curhan Ford
- Natixis Bleichroeder
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
